Oppenheimer Initiates Coverage on Eurand (EURX)
Oppenheimer initiates coverage on Eurand (Nasdaq: EURX) with an Outperform. Price target $16.
To see more analyst ratings on EURX Click Here.
Eurand N.V. (Eurand), formerly known as Eurand B.V., is a specialty pharmaceutical company.
Related Categories
New CoverageStocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
